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Coronavirus disease 2019 (COVID-19) has been associated with a
wide spectrum of symptoms, and neurological complications
characterized by anosmia, hypogeusia, seizures, hemorrhagic
stroke, neuromuscular problems, and encephalopathy have been
reported in over 30% of cases.1 The pathogenesis is still unclear,
although underlying genetic susceptibility, viral invasion, and
cytokine storm may play a role.2 We describe a girl with COVID19eassociated encephalopathy characterized by focal seizures and
central apnea.
This 14-year-old girl with no prior medical history presented
with six days of fever, nasal congestion, and myalgia, followed by
three generalized tonic-clonic seizures with perioral cyanosis. The
patient was initially lethargic, but otherwise had a normal neurological examination. She had ongoing hypoxia and chest x-ray
revealed bilateral inﬁltrates; she subsequently tested positive for
COVID-19 polymerase chain reaction via nasopharyngeal sampling.
Laboratory evaluation was unremarkable, cerebrospinal ﬂuid proﬁle and culture were normal, and cerebrospinal ﬂuid polymerase
chain reaction for COVID-19 was negative. The patient was started
on levetiracetam and a 10-day course of remdesivir.
Two days after admission, she experienced two apneic episodes,
necessitating intubation. Electroencephalography monitoring
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during these apneic periods exhibit an epileptiform correlate. There
were only mild elevations in inﬂammatory markers, and the serum
cytokine panel was normal (see Table).
Magnetic resonance imaging of brain and spine was normal.
Over the following week, she remained intubated despite minimal
sedation; efforts made to decrease ventilatory support resulted in
rising serum carbon dioxide without any response in respiratory
drive. Her mental status improved over another week and she was
able to follow commands, but only rarely had spontaneous respirations on the ventilator. Caffeine was initiated, and two days later
her apnea improved to one to four brief, self-resolved episodes
daily.
An apneic episode at this point was associated with lip smacking; further electroencephalography monitoring revealed a seizure
correlate arising from right posterior temporal region. Lacosamide
was added with complete resolution of apneic events and the patient was extubated. On follow-up, the patient was doing well
without further seizures.
Discussion
Central apnea occurs because of impairment of a pontomedullary pacemaker resulting in lack of activation of inspiratory thoracic
muscles. Both acquired and genetic disorders can result in sleeprelated alveolar hypoventilation despite normal neuromuscular
and pulmonary function. A congenital cause is rare, and typically
attributed to central alveolar hypoventilation syndrome from
PHOX2B mutations that result in disordered central and peripheral
chemoreception.3 Affected individuals have an abnormal respiratory drive that manifests as shallow breathing with no distress or
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TABLE.
Relevant Laboratory Results and Values of Inﬂammatory Markers on Initial
Presentation
Test

Value

Normal Range

Fibrinogen
D-dimer
LDH
Ferritin
Procalcitonin
CRP
ESR
Serum cytokine panel:
Interferon-g
Interleukin 1b
Interleukin 10
Interleukin 12
Interleukin 13
Interleukin 17
Interleukin 2
Interleukin 2 receptor
Interleukin 4
Interleukin 5
Interleukin 6
Interleukin 8
Tumor necrosis factor

274
234[
350[
314[
0.07
6.6[
21[

300-520 mg/dL
<230 ng/mL
135-225 U/L
15-150 ng/mL
0.02-0.1 ng/mL
<5 mg/L
<20 mm/hr

<5
6
<5
<5
<5
<5
12
783
<5
<5
<5
<5
<5

5 pg/mL
36 pg/mL
18 pg/mL
6 pg/mL
5 pg/mL
13 pg/mL
12 pg/mL
1033 pg/mL
5 pg/mL
5 pg/mL
5 pg/mL
5 pg/mL
22 pg/mL

Abbreviations:
CRP ¼ C-reactive protein
ESR ¼ Erythrocyte sedimentation rate
LDH ¼ Lactate dehydrogenase

arousal in response to hypoxemia and hypercapnia. Acquired causes of central apnea abound because of brainstem, diencephalic, or

spinal cord disorders, and have been reported in cases of viral encephalitis, such as dengue.4
In contrast to persistent and continuous central apnea, intermittent apneic events are well known to correlate with seizures.
Studies have demonstrated that the hippocampus and amygdala
are limbic breathing control regions.5 Sudden unexpected death in
epilepsy is a severe complication of patients with refractory epilepsy, often thought to be related to ictal or postictal central apnea
with hypoventilation.6 This patient brings attention to a previously
unreported encephalopathy with seizures and central respiratory
disturbance associated with COVID-19 in the absence of inﬂammatory biomarkers and normal magnetic resonance imaging of the
brain. It remains to be seen whether COVID-19 may precipitate an
increase in sudden unexpected death in epilepsy in patients with
epilepsy.
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